Furthermore, we validated that the concentrations of GM‐CSF, IL‐23 and IL‐17A were elevated in patients with SL‐induced recurrent AU and decreased in patients receiving conventional therapy. This evidence concerns the gene IL17A and alopecia universalis congenita.